Breaking News
Investing Pro 0
Extended Sale! Save on premium data with Claim 60% OFF

Chile president replaces health minister amid COVID-19 deaths controversy

Published Jun 13, 2020 02:00PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

SANTIAGO (Reuters) - Chile President Sebastian Pinera on Saturday replaced Health Minister Jaime Manalich amid controversy over the country's figures for deaths from the coronavirus outbreak.

Pinera said Manalich had spared "no effort" in carrying out his "difficult and noble duty" to protect Chileans` health. He replaced him with Oscar Enrique Paris, an academic and medical doctor.

The sudden reshuffle comes as Chile faces its toughest month in the pandemic so far, with spiraling active cases and deaths rates.

The country now has the highest number of confirmed cases per million people in Latin America, reporting 167,355 cases on Saturday and 3,101 deaths.

Manalich, a tough-talking kidney specialist who once ran one of Chile´s top hospitals, has won praise for an aggressive campaign to keep hospitals supplied with ventilators and protective equipment and leading detailed daily press conferences.

But there have been frequent reports of spats among health ministry officials, and Manalich has been criticised by opposition politicians, mayors, medical experts and social groups for refusing to release more detailed contagion data or apply lockdowns sooner and for successive changes in criteria for recording deaths and cases.

On Saturday, a Chilean investigative website, Ciper, reported that the health ministry had told the World Health Organisation that as many as 5,000 deaths in the country were linked to coronavirus.

The health ministry's statistics department reported figures to the global body of people who had died after testing positive for coronavirus test but also deaths suspected to be linked to COVID-19, the respiratory disease caused by the novel coronavirus.

The new minister, Enrique Paris, is a former head of the Chilean College of Doctors (Colmed) and a university deacon.

José Miguel Bernucci, Colmed's national secretary, welcomed the appointment, saying he was looking forward to a more consensual approach and a "change in strategy to jointly confront the pandemic."

Chile president replaces health minister amid COVID-19 deaths controversy
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email